Oestrogen receptor alpha in pulmonary hypertension

Audrey F. Wright, Marie-Ann Ewart, Kirsty Mair, Margaret Nilsen, Yvonne Dempsie, Lynn Loughlin, Margaret R. MacLean

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aims Pulmonary arterial hypertension (PAH) occurs more frequently in women with mutations in bone morphogenetic protein receptor type 2 (BMPR2) and dysfunctional BMPR2 signalling underpinning heritable PAH. We have previously shown that serotonin can uncover a pulmonary hypertensive phenotype in BMPR2+/- mice and that oestrogen can increase serotinergic signalling in human pulmonary arterial smooth muscle cells (hPASMCs). Hence, here we wished to characterize the expression of oestrogen receptors (ERs) in male and female human pulmonary arteries and have examined the influence of oestrogen and serotonin on BMPR2 and ERα expression. Methods and results By immunohistochemistry, we showed that ERα, ERβ, and G-protein-coupled receptors are expressed in human pulmonary arteries localizing mainly to the smooth muscle layer which also expresses the serotonin transporter (SERT). Protein expression of ERα protein was higher in female PAH patient hPASMCs compared with male and serotonin also increased the expression of ERα. 17β-estradiol induced proliferation of hPASMCs via ERα activation and this engaged mitogen-activated protein kinase and Akt signalling. Female mice over-expressing SERT (SERT+ mice) develop PH and the ERα antagonist MPP attenuated the development of PH in normoxic and hypoxic female SERT+ mice. The therapeutic effects of MPP were accompanied by increased expression of BMPR2 in mouse lung. Conclusion ERα is highly expressed in female hPASMCs from PAH patients and mediates oestrogen-induced proliferation of hPASMCs via mitogen-activated protein kinase and Akt signalling. Serotonin can increase ERα expression in hPASMCs and antagonism of ERα reverses serotonin-dependent PH in the mouse and increases BMPR2 expression.

LanguageEnglish
Pages206-216
Number of pages11
JournalCardiovascular Research
Volume106
Issue number2
DOIs
Publication statusPublished - 12 Mar 2015

Fingerprint

Type II Bone Morphogenetic Protein Receptors
Estrogen Receptor alpha
Pulmonary Hypertension
Smooth Muscle Myocytes
Lung
Serotonin Plasma Membrane Transport Proteins
Serotonin
Estrogens
Mitogen-Activated Protein Kinases
Pulmonary Artery
Therapeutic Uses
G-Protein-Coupled Receptors
Estrogen Receptors
Smooth Muscle
Estradiol
Proteins
Immunohistochemistry
Phenotype
Mutation

Keywords

  • BMPR2
  • oestrogen
  • oestrogen receptor alpha
  • pulmonary hypertension
  • serotonin

Cite this

Wright, Audrey F. ; Ewart, Marie-Ann ; Mair, Kirsty ; Nilsen, Margaret ; Dempsie, Yvonne ; Loughlin, Lynn ; MacLean, Margaret R. / Oestrogen receptor alpha in pulmonary hypertension. In: Cardiovascular Research. 2015 ; Vol. 106, No. 2. pp. 206-216.
@article{b279f98d0e43421186a5d0891bedfcee,
title = "Oestrogen receptor alpha in pulmonary hypertension",
abstract = "Aims Pulmonary arterial hypertension (PAH) occurs more frequently in women with mutations in bone morphogenetic protein receptor type 2 (BMPR2) and dysfunctional BMPR2 signalling underpinning heritable PAH. We have previously shown that serotonin can uncover a pulmonary hypertensive phenotype in BMPR2+/- mice and that oestrogen can increase serotinergic signalling in human pulmonary arterial smooth muscle cells (hPASMCs). Hence, here we wished to characterize the expression of oestrogen receptors (ERs) in male and female human pulmonary arteries and have examined the influence of oestrogen and serotonin on BMPR2 and ERα expression. Methods and results By immunohistochemistry, we showed that ERα, ERβ, and G-protein-coupled receptors are expressed in human pulmonary arteries localizing mainly to the smooth muscle layer which also expresses the serotonin transporter (SERT). Protein expression of ERα protein was higher in female PAH patient hPASMCs compared with male and serotonin also increased the expression of ERα. 17β-estradiol induced proliferation of hPASMCs via ERα activation and this engaged mitogen-activated protein kinase and Akt signalling. Female mice over-expressing SERT (SERT+ mice) develop PH and the ERα antagonist MPP attenuated the development of PH in normoxic and hypoxic female SERT+ mice. The therapeutic effects of MPP were accompanied by increased expression of BMPR2 in mouse lung. Conclusion ERα is highly expressed in female hPASMCs from PAH patients and mediates oestrogen-induced proliferation of hPASMCs via mitogen-activated protein kinase and Akt signalling. Serotonin can increase ERα expression in hPASMCs and antagonism of ERα reverses serotonin-dependent PH in the mouse and increases BMPR2 expression.",
keywords = "BMPR2, oestrogen, oestrogen receptor alpha, pulmonary hypertension, serotonin",
author = "Wright, {Audrey F.} and Marie-Ann Ewart and Kirsty Mair and Margaret Nilsen and Yvonne Dempsie and Lynn Loughlin and MacLean, {Margaret R.}",
year = "2015",
month = "3",
day = "12",
doi = "10.1093/cvr/cvv106",
language = "English",
volume = "106",
pages = "206--216",
journal = "Cardiovascular Research",
issn = "0008-6363",
number = "2",

}

Oestrogen receptor alpha in pulmonary hypertension. / Wright, Audrey F.; Ewart, Marie-Ann; Mair, Kirsty; Nilsen, Margaret; Dempsie, Yvonne; Loughlin, Lynn; MacLean, Margaret R.

In: Cardiovascular Research, Vol. 106, No. 2, 12.03.2015, p. 206-216.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oestrogen receptor alpha in pulmonary hypertension

AU - Wright, Audrey F.

AU - Ewart, Marie-Ann

AU - Mair, Kirsty

AU - Nilsen, Margaret

AU - Dempsie, Yvonne

AU - Loughlin, Lynn

AU - MacLean, Margaret R.

PY - 2015/3/12

Y1 - 2015/3/12

N2 - Aims Pulmonary arterial hypertension (PAH) occurs more frequently in women with mutations in bone morphogenetic protein receptor type 2 (BMPR2) and dysfunctional BMPR2 signalling underpinning heritable PAH. We have previously shown that serotonin can uncover a pulmonary hypertensive phenotype in BMPR2+/- mice and that oestrogen can increase serotinergic signalling in human pulmonary arterial smooth muscle cells (hPASMCs). Hence, here we wished to characterize the expression of oestrogen receptors (ERs) in male and female human pulmonary arteries and have examined the influence of oestrogen and serotonin on BMPR2 and ERα expression. Methods and results By immunohistochemistry, we showed that ERα, ERβ, and G-protein-coupled receptors are expressed in human pulmonary arteries localizing mainly to the smooth muscle layer which also expresses the serotonin transporter (SERT). Protein expression of ERα protein was higher in female PAH patient hPASMCs compared with male and serotonin also increased the expression of ERα. 17β-estradiol induced proliferation of hPASMCs via ERα activation and this engaged mitogen-activated protein kinase and Akt signalling. Female mice over-expressing SERT (SERT+ mice) develop PH and the ERα antagonist MPP attenuated the development of PH in normoxic and hypoxic female SERT+ mice. The therapeutic effects of MPP were accompanied by increased expression of BMPR2 in mouse lung. Conclusion ERα is highly expressed in female hPASMCs from PAH patients and mediates oestrogen-induced proliferation of hPASMCs via mitogen-activated protein kinase and Akt signalling. Serotonin can increase ERα expression in hPASMCs and antagonism of ERα reverses serotonin-dependent PH in the mouse and increases BMPR2 expression.

AB - Aims Pulmonary arterial hypertension (PAH) occurs more frequently in women with mutations in bone morphogenetic protein receptor type 2 (BMPR2) and dysfunctional BMPR2 signalling underpinning heritable PAH. We have previously shown that serotonin can uncover a pulmonary hypertensive phenotype in BMPR2+/- mice and that oestrogen can increase serotinergic signalling in human pulmonary arterial smooth muscle cells (hPASMCs). Hence, here we wished to characterize the expression of oestrogen receptors (ERs) in male and female human pulmonary arteries and have examined the influence of oestrogen and serotonin on BMPR2 and ERα expression. Methods and results By immunohistochemistry, we showed that ERα, ERβ, and G-protein-coupled receptors are expressed in human pulmonary arteries localizing mainly to the smooth muscle layer which also expresses the serotonin transporter (SERT). Protein expression of ERα protein was higher in female PAH patient hPASMCs compared with male and serotonin also increased the expression of ERα. 17β-estradiol induced proliferation of hPASMCs via ERα activation and this engaged mitogen-activated protein kinase and Akt signalling. Female mice over-expressing SERT (SERT+ mice) develop PH and the ERα antagonist MPP attenuated the development of PH in normoxic and hypoxic female SERT+ mice. The therapeutic effects of MPP were accompanied by increased expression of BMPR2 in mouse lung. Conclusion ERα is highly expressed in female hPASMCs from PAH patients and mediates oestrogen-induced proliferation of hPASMCs via mitogen-activated protein kinase and Akt signalling. Serotonin can increase ERα expression in hPASMCs and antagonism of ERα reverses serotonin-dependent PH in the mouse and increases BMPR2 expression.

KW - BMPR2

KW - oestrogen

KW - oestrogen receptor alpha

KW - pulmonary hypertension

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=84929074620&partnerID=8YFLogxK

UR - https://academic.oup.com/cardiovascres

U2 - 10.1093/cvr/cvv106

DO - 10.1093/cvr/cvv106

M3 - Article

VL - 106

SP - 206

EP - 216

JO - Cardiovascular Research

T2 - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -